Skip to main content

Table 2 Proportions of aggrecanase and MMP G1 degradation products

From: Aggrecan heterogeneity in articular cartilage from patients with osteoarthritis

Patient ID Aggrecanase G1a MMP G1a Ratio (G1-Agg/G1-MMP)
3 338 290 1.16
4 579 223 2.59
5 251 302 0.83
6 388 165 2.35
7 516 335 1.54
8 456 156 2.92
9 352 352 1.00
10 671 423 1.58
11 904 574 1.57
12 396 139 2.84
13 643 171 3.76
14 226 59.9 3.77
15 263 116 2.26
16 491 190 2.58
17 524 392 1.34
18 503 110 4.57
19 23.2 111 0.21
20 515 200 2.57
21 386 306 1.26
22 452 271 1.66
23 240 177 1.36
24 518 259 2.00
25 218 10.8 20.2
26 323 45.4 7.12
27 405 480 0.84
28 256 280 0.91
29 324 273 1.18
30 726 604 1.20
31 215 96.6 2.23
32 254 243 1.04
33 418 213 1.96
34 56.0 27.2 2.06
  1. aPixel intensity of G1 bands determined by densitometry